Chapter Three

Pure Food and Drug Act

1906

Required manufactures to indicate the amounts of alcohol, morphine, opium, cocaine, heroin, and marijuana extract on the label of each product

 

This gave the consumer the information necessary to make an informed decision

The Sherley Amendment

Added the requirement to existing law that labels should not contain "any statement … regarding the curative or therapeutic effect… which is false or fraudulent."

 

This amendment did not improve drug products but encouraged pharmaceutical companied to be more vague in their advertisements.

Federal Food, Drug, and Cosmetic Act

1938

The FDA was given control over drug safety after 107 people were killed by product produced by a drug company

 

Companies now had to file applications for new drugs with the government that they were safe

They did not have to be effective

Durham-Humphrey Amendment

1951

Established the criteria which determine whether a drug is to be classified as prescription or non-prescription

Durham-Humphrey Amendment

If a drug does not fall into one of the following categories it is considered nonprescription

The drug is habit-forming

The drug is not safe for self-medication due to its toxicity

The drug is new and lacks safety

Kefauver and Harris Amendment 1962

Required

Manufactures to demonstrate effectiveness and safety of drug

Allowed FDA

Withdraw approval of a drug

Regulate/evaluate drug testing

New Drugs

All companies must follow a series of steps when seeking approval to market a new drug

Preclinical research and development

Clinical research and development

Permission to market

New Drug: Exceptions

Fast-track rule

Orphan drug law

Drug Advertising

Estimated cost for OTC drug advertising

Estimated cost for Prescription drug advertising

The Comprehensive Drug Abuse Prevention and Control Act of 1970

Divided drugs with abuse potential into categories:

Schedule I through V

 

Schedule I

The drug or substance has high potential for abuse

The drug or substance has no currently accepted medical use in treatment in the US

There is a lack of accepted safety for use under medical supervision

 

Schedule II

The drug or substance has high potential for abuse

The drug or substance has a currently accepted medical use in treatment in the US

Abuse of the drug may lead to severe dependence

 

Schedule III

The drug or substance has less of a potential for abuse than in I and II

The drug or substance has a currently accepted medical use in treatment in the US

Abuse of the drug may lead to moderate or low dependence

 

Schedule IV

The drug or substance has low potential for abuse relative to III

The drug or substance has a currently accepted medical use in treatment in the US

Abuse of the drug may lead to limited dependence relative to III

 

Schedule V

The drug or substance has low potential for abuse relative to IV

The drug or substance has a currently accepted medical use in treatment in the US

Abuse of the drug may lead to limited dependence relative to IV

Federal Trafficking Penalties

Schedule 1st 2nd

I Not < 5yr Not< 20

II Not < 5yr Not< 20

III Not > 5yr Not >10

IV Not > 3yr Not >6

V Not > 1yr Not >2

Supply Reduction

Drug reduction policy aimed at reducing the supply of illegal drugs and controlling therapeutic drugs

Demand Reduction

Attempts to decrease individuals tendency to use drugs primarily by reformulating values and behaviors

Inoculation

A method of abuse prevention that protects drug users by teaching them responsibility.

Oral Quiz

Can the FDA withdraw approval of an existing drug?

A drug must go through how many steps to become approved?

List the categories of drugs[sched]

What schedule drug is Marijuana?

Assignment:

Read Chapter #4, Addictive Behavior and Treating Drug Dependence (16 pgs.)

 

 

Be ready for a QUIZ!!!